Removal of Psychotropic Drugs by Hemoadsorption with the HA380 Cartridge
Blood Purification · 2025
DOI: 10.1159/000547371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2025. Verfasst von Taku Furukawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia, taku…. Hauptthemen laut MEDLINE: Psychotropic Drugs, Valproic Acid, Citalopram, Hemoperfusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
Psychotropic drug intoxication may require urgent management. Hemoadsorption (HA) may detoxify blood in such cases, but its effect has not been quantified.
Methods
We studied in vivo removal of valproate, quetiapine, and escitalopram with HA using the Jafron HA380 cartridge in six sheep. We measured the removal ratio (RR) and clearance (CL) of each agent over time.
Results
Mean sorbent-based valproate RR was initially 55.8% (CL: 58.2 mL/min) but declined to negligible levels at 120 min. The mean initial RR for quetiapine was >90% and remained high (72%) at 4 h with CL of 87.2 mL/min at 10 min and 68.7 mL/min at 240 min. The mean RR of escitalopram exceeded 90% at 10 min and decreased to 66.9% at 4 h. The mean CL was 88.0 mL/min at 10 min and 63.2 mL/min at 240 min.
Conclusion
HA with the HA380 cartridge achieves effective removal of valproate, quetiapine, and escitalopram. For valproate, adsorptive performance progressively declined over the 4-h treatment period. In contrast, for quetiapine and escitalopram, the function remained substantial for up to 4 h. Further research is required to optimize HA strategies for these drugs and facilitate clinical translation of HA-based blood detoxification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Preclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia, taku.furukawa@florey.edu.au.
- Preclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
- Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Anesthesia, Austin Hospital, Melbourne, Victoria, Australia.
- Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.
- Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.
Zitieren
APA
Furukawa, T., Lankadeva, Y. R., Baldwin, I. C., Ow, P. C. C., Hood, S., Eap, C. B., Schneider, A., Decosterd, L. A., & Bellomo, R. (2025). Removal of Psychotropic Drugs by Hemoadsorption with the HA380 Cartridge. Blood Purification. https://doi.org/10.1159/000547371
Vancouver
Furukawa T, Lankadeva YR, Baldwin IC, Ow PCC, Hood S, Eap CB, et al. Removal of Psychotropic Drugs by Hemoadsorption with the HA380 Cartridge. Blood Purification. 2025. doi:10.1159/000547371
BibTeX
@article{Furukawa2025,
author = {Furukawa, Taku and Lankadeva, Yugeesh R and Baldwin, Ian C and Ow, Pei Chen Connie and Hood, Sally and Eap, Chin Bin and Schneider, Antoine and Decosterd, Laurent A and Bellomo, Rinaldo},
title = {Removal of Psychotropic Drugs by Hemoadsorption with the HA380 Cartridge},
journal = {Blood Purification},
year = {2025},
doi = {10.1159/000547371}
}
EUVIMED